glyburide has been researched along with fluorobenzenes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Perrone, T | 1 |
Hilgendorf, C; Nordell, P; Winiwarter, S | 1 |
1 trial(s) available for glyburide and fluorobenzenes
Article | Year |
---|---|
Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
Topics: Adipokines; Aged; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fatty Liver; Female; Fluorobenzenes; Glucose Clamp Technique; Glyburide; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Intra-Abdominal Fat; Italy; Lipids; Male; Metformin; Middle Aged; Pioglitazone; Pyrimidines; Rosuvastatin Calcium; Subcutaneous Fat; Sulfonamides; Thiazolidinediones; Time Factors; Treatment Outcome; Ultrasonography | 2013 |
1 other study(ies) available for glyburide and fluorobenzenes
Article | Year |
---|---|
Resolving the distribution-metabolism interplay of eight OATP substrates in the standard clearance assay with suspended human cryopreserved hepatocytes.
Topics: Biological Transport; Cryopreservation; Drug Stability; Fluorobenzenes; Glyburide; HEK293 Cells; Hepatocytes; Humans; Kinetics; Liver; Liver-Specific Organic Anion Transporter 1; Metabolic Clearance Rate; Organic Anion Transporters; Principal Component Analysis; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tissue Distribution | 2013 |